Cubist Systematic Strategies, LLC Vanda Pharmaceuticals Inc. Transaction History

Cubist Systematic Strategies, LLC

$15.8 Billion
Q3 2024

A detailed history of Cubist Systematic Strategies, LLC transactions in Vanda Pharmaceuticals Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 99,342 shares of VNDA stock, worth $506,644. This represents 0.0% of its overall portfolio holdings.

Number of Shares

99,342

Holding current value

$506,644

% of portfolio

0.0%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$4.61 - $6.34 $457,966 - $629,828	99,342 New	99,342 $465,000
Q1 2024 May 15, 2024	SELL	$3.47 - $4.61 $431,279 - $572,967	-124,288 Reduced 87.03%	18,529 $76,000
Q4 2023 Feb 14, 2024	SELL	$3.38 - $4.58 $258,546 - $350,337	-76,493 Reduced 34.88%	142,817 $602,000
Q3 2023 Nov 14, 2023	BUY	$4.28 - $6.57 $401,438 - $616,226	93,794 Added 74.73%	219,310 $947,000
Q2 2023 Aug 14, 2023	BUY	$5.9 - $6.95 $581,486 - $684,971	98,557 Added 365.58%	125,516 $827,000
Q1 2023 May 15, 2023	SELL	$6.18 - $7.99 $1.9 Million - $2.45 Million	-306,676 Reduced 91.92%	26,959 $183,000
Q4 2022 Feb 14, 2023	BUY	$6.87 - $10.96 $1.1 Million - $1.76 Million	160,162 Added 92.33%	333,635 $2.47 Million
Q3 2022 Nov 14, 2022	BUY	$9.44 - $11.76 $911,139 - $1.14 Million	96,519 Added 125.42%	173,473 $1.71 Million
Q2 2022 Aug 15, 2022	SELL	$9.31 - $11.84 $55,496 - $70,578	-5,961 Reduced 7.19%	76,954 $839,000
Q1 2022 May 16, 2022	SELL	$10.84 - $16.55 $162,296 - $247,786	-14,972 Reduced 15.3%	82,915 $938,000
Q4 2021 Feb 14, 2022	BUY	$15.69 - $21.14 $928,314 - $1.25 Million	59,166 Added 152.8%	97,887 $1.54 Million
Q3 2021 Nov 15, 2021	SELL	$15.35 - $21.27 $107,158 - $148,485	-6,981 Reduced 15.28%	38,721 $664,000
Q2 2021 Aug 16, 2021	SELL	$15.71 - $21.51 $1.08 Million - $1.48 Million	-68,742 Reduced 60.07%	45,702 $983,000
Q1 2021 May 17, 2021	BUY	$13.42 - $20.28 $1.06 Million - $1.6 Million	79,078 Added 223.6%	114,444 $1.72 Million
Q4 2020 Feb 16, 2021	SELL	$9.77 - $13.81 $473,962 - $669,950	-48,512 Reduced 57.84%	35,366 $465,000
Q3 2020 Nov 16, 2020	SELL	$9.32 - $12.02 $183,743 - $236,974	-19,715 Reduced 19.03%	83,878 $810,000
Q2 2020 Aug 14, 2020	BUY	$9.66 - $12.02 $793,201 - $986,986	82,112 Added 382.25%	103,593 $1.19 Million
Q1 2020 May 15, 2020	SELL	$7.5 - $16.8 $488,032 - $1.09 Million	-65,071 Reduced 75.18%	21,481 $223,000
Q4 2019 Feb 14, 2020	SELL	$12.38 - $17.47 $210,794 - $297,461	-17,027 Reduced 16.44%	86,552 $1.42 Million
Q3 2019 Nov 14, 2019	BUY	$12.27 - $15.79 $255,400 - $328,668	20,815 Added 25.15%	103,579 $1.38 Million
Q2 2019 Aug 14, 2019	BUY	$13.37 - $18.85 $234,844 - $331,100	17,565 Added 26.94%	82,764 $1.17 Million
Q1 2019 May 15, 2019	BUY	$17.59 - $31.05 $716,722 - $1.27 Million	40,746 Added 166.63%	65,199 $1.2 Million
Q4 2018 Feb 14, 2019	SELL	$18.97 - $31.47 $849,059 - $1.41 Million	-44,758 Reduced 64.67%	24,453 $639,000
Q3 2018 Nov 14, 2018	BUY	$18.25 - $23.0 $1.26 Million - $1.59 Million	69,211 New	69,211 $1.59 Million
Q1 2018 May 15, 2018	SELL	$14.05 - $20.2 $33,115 - $47,611	-2,357 Closed	0 $0
Q4 2017 Feb 14, 2018	SELL	$12.85 - $18.1 $295,935 - $416,843	-23,030 Reduced 90.72%	2,357 $36,000
Q3 2017 Nov 14, 2017	BUY	$15.4 - $18.85 $390,959 - $478,544	25,387	25,387 $454,000

Others Institutions Holding VNDA

# of Institutions

161

Shares Held

45.5M

Call Options Held

150K

Put Options Held

33.6K

View Full List

About Vanda Pharmaceuticals Inc.

Ticker VNDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,561,500
Market Cap $288M
Description
Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company's marketed products include HETLIOZ for the treatment of non-24-hour sleep-wake disorders; and Fanapt oral tablets for the treatment of schizophrenia. Its products under developme...

More about VNDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cubist Systematic Strategies, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cubist Systematic Strategies, LLC with notifications on news.

Account

Cubist Systematic Strategies, LLC Vanda Pharmaceuticals Inc. Transaction History